| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 09/26/2002 | US20020137110 Detecting apoptosis |
| 09/26/2002 | US20020137049 Pablo, a polypeptide that interacts with Bcl-xL, and uses related thereto |
| 09/26/2002 | US20020136736 Or prophylactically or therapeutically effective fragment thereof in admixture with a pharmaceutically acceptable carrier |
| 09/26/2002 | CA2469846A1 New interferon beta-like molecules |
| 09/26/2002 | CA2441902A1 Chimpanzee erythropoietin (chepo) - immunoadhesins |
| 09/26/2002 | CA2440272A1 Nucleic acid-associated proteins |
| 09/26/2002 | CA2440028A1 Rearranged squamous cell carcinoma antigen genes ii |
| 09/26/2002 | CA2438483A1 Histidine phosphatase interacting protein with 240kd |
| 09/25/2002 | EP1243597A2 Receptors for human interleukin-12 |
| 09/25/2002 | EP1242599A2 Method for obtaining human cdc25 phosphatases and method for identifying human cdc25 phosphatase modulators |
| 09/25/2002 | EP1242458A2 Brain specific binding members |
| 09/25/2002 | EP1242457A1 Intrabodies with defined framework that is stable in a reducing environment and applications thereof |
| 09/25/2002 | EP1242122A2 Delivery of proteins across polar epithelial cell layers |
| 09/25/2002 | EP1242049A1 Hla class i a2 tumor associated antigen peptides and vaccine compositions |
| 09/25/2002 | EP0972020B1 Insulin-like growth factor agonist molecules |
| 09/25/2002 | EP0652966B1 Method of increasing expression of viral proteins |
| 09/25/2002 | CN1371424A Activatable recombinant neurotoxins |
| 09/25/2002 | CN1371416A Human CTLA-4 antibodies and their uses |
| 09/24/2002 | US6455685 Detecting modulators of immune response; obtain nucleotide sequences, incubate with modulator, remove unbound modulator, detect bound complexes |
| 09/24/2002 | US6455683 Nucleotidesequences coding protein for use in the prevetion and treatment of infectious, inflammatory and allergic diseases |
| 09/24/2002 | US6455673 Polypeptide for use as vaccine in prevention of microorganismal infections |
| 09/24/2002 | US6455283 Amino acid sequence of polypeptide; for recombinant cell culture production of this growth factor; anticarcinogenic agents; wound healing agents |
| 09/24/2002 | CA2065325C Cdr grafted anti-cea antibodies and their production |
| 09/24/2002 | CA1341388C Hybrid pesticidal toxins |
| 09/19/2002 | WO2002072630A2 Nucleic acid-associated proteins |
| 09/19/2002 | WO2002072608A2 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW-AFFINITY FCηRECEPTORS |
| 09/19/2002 | WO2002072605A2 Expression technology for proteins containing a hybrid isotype antibody moiety |
| 09/19/2002 | WO2002072600A2 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| 09/19/2002 | WO2002022871A3 Polymorphic bone morphogenetic protein 2 |
| 09/19/2002 | WO2002017949A9 Novel functions for dp214 |
| 09/19/2002 | WO2002014355A3 Novel mitogen activated kinase |
| 09/19/2002 | WO2001030843A9 Ligand activated transcriptional regulator proteins |
| 09/19/2002 | US20020133001 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 09/19/2002 | US20020132991 Purifying anionic target proteins from a sample; obtain mixed protein samples, incubate with reversibility binding substrate, purify anionic target proteins |
| 09/19/2002 | US20020132979 Monoclonal antibody for use in the diagnosis, prevention and treatment of tumors |
| 09/19/2002 | CA2440221A1 Expression technology for proteins containing a hybrid isotype antibody moiety |
| 09/19/2002 | CA2437958A1 Polymeric immunoglobulin fusion proteins that target low-affinity fc.gamma.receptors |
| 09/19/2002 | CA2437756A1 Nucleic acid-associated proteins |
| 09/19/2002 | CA2434762A1 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| 09/18/2002 | EP1241186A2 Human growth arrest specific gene 6 (gas-6) and nucleic acids encoding the same |
| 09/18/2002 | EP1241185A2 Human protocadherin-like protein and nucleic acids encoding it |
| 09/18/2002 | EP1241184A2 Human synaptogyrin-like protein and nucleic acids encoding the same |
| 09/18/2002 | EP1240337A2 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 09/18/2002 | EP1240331A2 i CHLAMYDIA /i ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 09/18/2002 | EP1240327A2 Interferon-like molecules and uses thereof |
| 09/18/2002 | EP1240317A2 Nucleic acid vaccination |
| 09/18/2002 | EP1240298A2 Detergent compositions comprising benefit agents |
| 09/18/2002 | EP1240197A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 09/18/2002 | EP1240196A2 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 09/18/2002 | EP1240195A2 Polynucleotides and polypeptides encoded thereby |
| 09/18/2002 | EP1239870A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 09/18/2002 | EP0614486B1 Targeted delivery of virus vector to mammalian cells |
| 09/18/2002 | CN1370182A Compounds and methods for therapy and diagnosis of lung cancer |
| 09/18/2002 | CN1370078A Prion protein peptides and uses thereof |
| 09/17/2002 | US6451997 Kits for detecting chromosomal rearrangements |
| 09/17/2002 | US6451764 VEGF-related protein |
| 09/17/2002 | US6451543 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 09/17/2002 | US6451541 Chaperones capable of binding to prion proteins and distinguishing the isoforms PrPc and PrPsc |
| 09/17/2002 | US6451523 Variant form of the receptor for the obese gene product. the invention relates to methods of detecting this receptor variant in cells and tissues of obese individuals. |
| 09/17/2002 | US6451315 Compounds and methods for the diagnosis and treatment of B. microti infection |
| 09/17/2002 | US6451313 Heterotetramer; expression vectors encoding heavy and light chains; viricides |
| 09/17/2002 | CA2047244C Genetically engineered immunoglobulins |
| 09/12/2002 | WO2002070722A1 Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts |
| 09/12/2002 | WO2002070711A1 Vaccine |
| 09/12/2002 | WO2002070706A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 09/12/2002 | WO2002070665A2 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| 09/12/2002 | WO2002070662A2 Three hybrid assay system |
| 09/12/2002 | WO2002070655A2 Mouse cytokine receptor |
| 09/12/2002 | WO2002070651A2 Viral reporter particles |
| 09/12/2002 | WO2002070565A2 High-affinity antagonists of elr-cxc chemokines |
| 09/12/2002 | WO2002070552A2 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF |
| 09/12/2002 | WO2002070549A2 Chimeric polypeptides of serum albumin and uses related thereto |
| 09/12/2002 | WO2002070005A1 Compositions of multimeric profilin for diagnosis and treatment of allergies |
| 09/12/2002 | WO2002069886A2 Modified proteins, designer toxins, and methods of making thereof |
| 09/12/2002 | WO2002022680A3 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine) |
| 09/12/2002 | WO2002014369A3 Human kininogen d5 domain polypeptides and their use |
| 09/12/2002 | WO2001083529A3 Immunoadhesin for the prevention of rhinovirus infection |
| 09/12/2002 | WO2001009192A9 Human monoclonal antibodies to prostate specific membrane antigen |
| 09/12/2002 | WO2000073801A3 Breast, gastric and prostate cancer associated antigens and uses therefor |
| 09/12/2002 | US20020127676 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 09/12/2002 | US20020127647 ATP-binding cassette transporter-like molecules and uses thereof |
| 09/12/2002 | US20020127638 Human metabotropic glutamate receptor 7 subtypes |
| 09/12/2002 | US20020127621 KUZ, a novel family of metalloproteases |
| 09/12/2002 | US20020127231 Extracellular domains of a heterodimeric protein operatively linked to immunoglobulin heavy and light chain polypeptides |
| 09/12/2002 | US20020127204 Improvements in or relating to protection against intracellular infection |
| 09/12/2002 | DE10109854A1 Polypeptide eines hdm2-Protein spezifischen murinen alpha/beta T-Zell Rezeptors, diese kodierende Nukleinsäuren und deren Verwendung Polypeptides of hdm2 protein specific murine alpha / beta T-cell receptor nucleic acids encoding these, and their use |
| 09/12/2002 | CA2445013A1 Polypeptides of an hdm2 protein-specific murine alpha/beta t-cell receptor, nucleic acids encoding these and their use |
| 09/12/2002 | CA2441476A1 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| 09/12/2002 | CA2439636A1 Mouse cytokine receptor |
| 09/12/2002 | CA2439628A1 Vaccine |
| 09/12/2002 | CA2439625A1 Compositions of multimeric profilin for diagnosis and treatment of allergies |
| 09/12/2002 | CA2439620A1 Viral reporter particles |
| 09/12/2002 | CA2439594A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 09/12/2002 | CA2439042A1 Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts |
| 09/12/2002 | CA2435277A1 Chimeric polypeptides of serum albumin and uses related thereto |
| 09/11/2002 | EP1239043A2 Fusion proteins comprising tumour necrosis factor receptor |
| 09/11/2002 | EP1238982A1 A Fluorescent Protein |
| 09/11/2002 | EP1238084A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/11/2002 | EP1238080A2 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 09/11/2002 | EP1238077A1 Tnfr/opg-like molecules and uses thereof |